Trump's cabinet and vice president, appointed for alignment with administration priorities, create significant structural barriers to invoking the 25th Amendment, as the process requires their affirmative declaration of incapacity. Republican congressional majorities as of mid-2026 further limit prospects for the two-thirds vote needed to sustain removal against presidential objection. No verified reports of health impairment or operational incapacity have emerged to shift these dynamics. Trader consensus at 96.9% against removal before 2027 reflects these institutional alignments and historical rarity of the amendment's contested use. Late-breaking medical developments or coordinated cabinet action could still introduce uncertainty within the resolution window.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日はい
$48,993 Vol.
$48,993 Vol.
はい
$48,993 Vol.
$48,993 Vol.
If the Vice President becomes Acting President via the process outlined in Section 3 of the 25th Amendment, it will not effect the resolution of this market. Only Trump’s removal from office via the process outlined in Section 4 of the 25th Amendment will qualify for a "Yes" resolution.
If Trump ceases to be POTUS before this market's expiration date for any other reason, this market may immediately resolve to "No".
The resolution source for this market will be official information from the US government.
マーケット開始日: Nov 5, 2025, 1:15 PM ET
Resolver
0x65070BE91...If the Vice President becomes Acting President via the process outlined in Section 3 of the 25th Amendment, it will not effect the resolution of this market. Only Trump’s removal from office via the process outlined in Section 4 of the 25th Amendment will qualify for a "Yes" resolution.
If Trump ceases to be POTUS before this market's expiration date for any other reason, this market may immediately resolve to "No".
The resolution source for this market will be official information from the US government.
Resolver
0x65070BE91...Trump's cabinet and vice president, appointed for alignment with administration priorities, create significant structural barriers to invoking the 25th Amendment, as the process requires their affirmative declaration of incapacity. Republican congressional majorities as of mid-2026 further limit prospects for the two-thirds vote needed to sustain removal against presidential objection. No verified reports of health impairment or operational incapacity have emerged to shift these dynamics. Trader consensus at 96.9% against removal before 2027 reflects these institutional alignments and historical rarity of the amendment's contested use. Late-breaking medical developments or coordinated cabinet action could still introduce uncertainty within the resolution window.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日


外部リンクに注意してください。
外部リンクに注意してください。
よくある質問